Improvement of voicing in patients with Parkinson’s disease by speech therapy
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with interest the article “Improvement of voicing in patients with Parkinson’s disease by speech therapy” by de Swart et al.1 and the Commentary by Rosenfeld.2 We would like to point out a number of inaccuracies in the de Swart et al. article that are misleading to the readership.
de Swart et al. state that they compared pitch limiting voice treatment (PLVT) with Lee Silverman voice treatment (LSVT). The use of the name LSVT is incorrect. LSVT is a well-researched treatment program administered in 16 individual 50-minute sessions in 1 month by a speech clinician who is trained and certified in its administration. Published data support both short- and long-term (2 years) improvement in speech and voice after 1 month of treatment,3 as well as improvements in swallowing and neural functioning.4,5⇓ In the de Swart et al. study, the authors simply stimulated patients to “speak loud/shout” in one 30-minute session and called this LSVT.
As we recently published,5 PET data pre–post LSVT …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Intensive speech treatment for patients with Parkinson's diseaseShort- and long-term comparison of two techniquesLorraine Olson Ramig, Stefanie Countryman, Christopher O'Brien et al.Neurology, December 01, 1996 -
Article
Motor speech patterns in Huntington diseaseSarah K. Diehl, Antje S. Mefferd, Ya-Chen Lin et al.Neurology, October 29, 2019 -
Brief Communications
Improvement of voicing in patients with Parkinson’s disease by speech therapyBert J.M. de Swart, S. C. Willemse, B.A.M. Maassen et al.Neurology, February 11, 2003 -
Articles
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s diseaseK. Kompoliti, Q.E. Wang, C.G. Goetz et al.Neurology, January 25, 2000